NCT06086353 - A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Transthyretin Amyloid Cardiomyopathy

Interventions

DRUG

Tafamidis

Patients on tafamidis will be observed

Trial Locations (3)

RECRUITING

Max Super Speciality Hospital, New Delhi

RECRUITING

AIG Hospital, Hyderabad

RECRUITING

Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore